GE HealthCare Technologies EBITDA Margin 2020-2023 | GEHC
GE HealthCare Technologies EBITDA Margin Historical Data | |||
---|---|---|---|
Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
2023-12-31 | $19.55B | $3.05B | 15.57% |
2023-09-30 | $19.28B | $3.15B | 16.31% |
2023-06-30 | $19.04B | $3.14B | 16.50% |
2023-03-31 | $18.71B | $3.20B | 17.12% |
2022-12-31 | $18.34B | $3.16B | 17.20% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $39.221B | $19.552B |
Chicago, IL-based GE Healthcare is a leading maker of medical imaging and patient-monitoring products and related equipment and services. Approximately half of GE Healthcare's revenue comes from equipment sales, with consumables and services accounting for the other half. GE Healthcare started operating as an independent company after its January 2023 spin-off from General Electric (GE). |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Inspire Medical Systems (INSP) | United States | $6.999B | 0.00 |
IRhythm Technologies (IRTC) | United States | $3.463B | 0.00 |
Axonics (AXNX) | United States | $3.394B | 0.00 |
10x Genomics (TXG) | United States | $3.206B | 0.00 |
Enovis (ENOV) | United States | $3.022B | 22.96 |
Azenta (AZTA) | United States | $2.872B | 234.09 |
Olink Holding AB (publ) (OLK) | Sweden | $2.869B | 0.00 |
Hims & Hers Health (HIMS) | United States | $2.629B | 0.00 |
Privia Health (PRVA) | United States | $2.135B | 94.68 |
Schrodinger (SDGR) | United States | $1.688B | 0.00 |
Omnicell (OMCL) | United States | $1.246B | 30.48 |
Phreesia (PHR) | United States | $1.154B | 0.00 |
Definitive Healthcare (DH) | United States | $0.793B | 0.00 |
Standard BioTools (LAB) | United States | $0.685B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.599B | 0.00 |
Talkspace (TALK) | United States | $0.520B | 0.00 |
Clover Health Investments (CLOV) | United States | $0.332B | 0.00 |
Health Catalyst (HCAT) | United States | $0.328B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.323B | 0.00 |
Pulmonx (LUNG) | United States | $0.281B | 0.00 |
American Well (AMWL) | United States | $0.156B | 0.00 |
P3 Health Partners (PIII) | United States | $0.152B | 0.00 |
Butterfly Network (BFLY) | United States | $0.147B | 0.00 |
Augmedix (AUGX) | United States | $0.136B | 0.00 |
MSP Recovery (LIFW) | United States | $0.131B | 0.00 |
Outset Medical (OM) | United States | $0.123B | 0.00 |
TruBridge (TBRG) | United States | $0.115B | 4.91 |
111 (YI) | China | $0.084B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.077B | 0.00 |
Future Health ESG (FHLT) | United States | $0.070B | 0.00 |
HeartBeam (BEAT) | United States | $0.052B | 0.00 |
Zepp Health (ZEPP) | China | $0.052B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.045B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.031B | 0.00 |
Movano (MOVE) | United States | $0.027B | 0.00 |
Cue Health (HLTH) | United States | $0.023B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.022B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.020B | 0.00 |
Akili (AKLI) | United States | $0.019B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.019B | 0.00 |
CareCloud (CCLD) | United States | $0.017B | 0.00 |
ETAO (ETAO) | United States | $0.015B | 0.00 |
Centogene (CNTG) | Germany | $0.013B | 0.00 |
Biotricity (BTCY) | United States | $0.012B | 0.00 |
Transgenomic (PRPO) | United States | $0.009B | 0.00 |
Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
HeartSciences (HSCS) | United States | $0.007B | 0.00 |
Syra Health (SYRA) | United States | $0.006B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
Zhongchao (ZCMD) | China | $0.003B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |